Sage Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sage Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Sage Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $8.73M, a 49.1% decline year-over-year.
  • Sage Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $39.3M, a 45.8% decline year-over-year.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $54.5M, a 25.7% decline from 2023.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $73.4M, a 19.1% increase from 2022.
  • Sage Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $61.6M, a 41.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $54.5M -$18.9M -25.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-11
2023 $73.4M +$11.8M +19.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-11
2022 $61.6M -$43M -41.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-11
2021 $105M +$8.64M +9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $96M -$57.2M -37.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $153M +$51.3M +50.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $102M +$66.4M +187% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $35.5M +$12.5M +54.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $23M +$7.78M +51.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $15.2M +$12.7M +507% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $2.51M +$2.45M +4018% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
2013 $61K Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.